Bionano Genomics, listed on the NASDAQ as BNGO, is scheduled to release its quarterly earnings on Monday, March 31, 2025. Analysts are predicting an earnings per share (EPS) of -$8.40 for the company. The upcoming announcement has garnered significant interest from investors who are hoping for results that exceed expectations and positive outlooks for the future. For more details, the full story can be found on Benzinga.com.